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TGFbregulation of chondrogenesis will also be discussed. Advances in our understanding of these
signaling pathways have led to promising advances in cartilage regeneration and tissue engi-
neering.
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Articular cartilage injury and repair is an issue of growing
importance around the world. Kurtz et al predict that the
number of total knee replacements will jump from 700,000
to 3.48 million annually by the year 2030.1 Although com-
mon, articular cartilage defects continue to hold a unique
clinical challenge due to its poor self-healing capacity,
which is largely due to its avascular nature. Current surgical
treatment options do not reliably produce hyaline cartilage
tissue in favor of fibrous tissue, and therefore remain
controversial. Deposition of fibrocartilage instead of hya-
line cartilage can lead to poor durability and rapid decline
in activity levels after 1 year. Therefore, there is a critical
need for more effective cartilage regenerative therapies.
The difficulty in obtaining a sufficiently large number of
chondrocytes for implantation could be overcome by uti-
lizing gene therapy to promote chondrogenesis from bone
marrow-derived mesenchymal stem cells (MSCs). However,
research regarding exogenous control over this multi-step
process has yielded only limited clinically applicable re-
sults. For this reason, the ability to differentiate MSCs into
chondrocytic cells, and subsequently implant these chon-
drocytes into cartilaginous defects is of significant thera-
peutic value.
MSCs are multipotent progenitor cells that can differ-
entiate into several lineages, including bone, cartilage, fat,
and muscle (Fig. 1). The proliferation and differentiation of
mesenchymal cells to chondrocytes, or chondrogenesis, is a
complex process that is regulated by a host of factors.
These factors include intracellular proteins, receptor li-
gands, and transcription factors; and a disruption in
signaling can result in defective chondrocyte production.
Here, we review the current understanding of the most
important biological regulators of chondrogenesis and how
these regulators interact to provide insight into their po-
tential for cartilage tissue engineering.Fibroblast growth factor (FGF) signaling
pathway
FGFs are a family of heparin-binding growth factors that are
involved in the proliferation and differentiation of a variety
of tissues. In general, FGFs are known to be positive regu-
lators of chondrogenesis and they appear to be involved
throughout the process. The most well studied and gener-
ally accepted function of the FGF family with regards to
chondrogenesis is its role in the proper patterning of
developing cartilage. The developing limb is divided into
two components: the apical ectodermal ridge (AER) and thelimb bud mesenchyme. The FGFs that are produced in the
AER, zone of polarizing activity (ZPA), and dorsal ectoderm
are necessary for early patterning events in the developing
embryo.2 The AER, which serves as the primary source of
FGF2, FGF4, FGF8, and FGF9 in the developing embryo, is
maintained by Wnt3 and FGF10 signaling.3,4 The effect of
FGF10 on the apical ectodermal ridge is the result of a
positive feedback loop with FGF8. FGF2, 4, and 8 serve as
important regulators of proximal-distal growth, and FGF2
has the additional function of priming MSCs for chon-
drocytic differentiation.5,6 The latter effect is mediated by
an increase in basal expression of prochondrogenic tran-
scription factor Sox9 and inactivation of IGF-I and TGF-b
signaling.5,7
Sequential expression of three FGFs has been shown to
impact the progression of chondrocyte differentiation and
maturation: FGF2, FGF9, and FGF18.8e10 As previously
stated, FGF2 administration is known to be sufficient to
enhance chondrocyte proliferation speed and prepare
chondroprogenitor cells for terminal differentiation; how-
ever, the mechanism by which FGF2 exerts these effects
has been largely unknown until recently.8 FGF2’s ability to
enhance chondrocyte proliferation speed is due to its
ability to enhance TGFb1 expression.11 Likewise, FGF2-
induced chondrocyte differentiation is a consequence of
FGF2-mediated downregulation of TGF-b2 expression.7
Given FGF2’s interactions with TGF-b1 and TGF-b2,
research sought to elucidate the impact of combining FGF2
with TGF-b3. It has now been determined that FGF2 is able
to induce chondrocyte differentiation and enhance prolif-
eration in the presence of TGF-b3, however these effects
are accompanied by inhibition of chondrocyte hypertro-
phy.12 In addition to its interactions with the TGF-b family
of proteins, combination of FGF2 with Wnt3a or a combi-
nation of platelet-derived growth factor (PDGF), insulin,
and TGF-b1 has been shown to be sufficient to support long-
term production of fully functional cartilage.13,14
While FGF2 is known to have a major impact on priming
chondroprogenitors for the chondrocyte differentiation
program, FGF9 and FGF18 are regulators for early chon-
drogenic differentiation, augmentation of ECM production,
and terminal chondrocyte hypertrophy.9 FGF9 can be both
prochondrogenic and proosteogenic depending on its
expression level and the cell population in which it is
expressed.15 FGF9 has not only been found to promote
chondrocyte hypertrophy at early stages but also to drive
the vascularization of the growth plate prior to osteo-
genesis.16 The multifunctionality of FGF9 is believed to be
the result of its ability to upregulate expression of other
prochondrogenic proteins, such as Sox9, Indian hedgehog
(Ihh), and Col2a1. FGF9 also upregulates proosteogenic
Figure 1 Currently hypothesized lineage-specific differentiation of mesenchymal stem cells (MSCs). Upon receiving appro-
priate differentiation cues, MSCs are multipotent stem cells and may undergo a cascade of differentiation stages, including pro-
genitor proliferation and expansion, lineage commitment and progression, differentiation and maturation, and subsequently
differentiate into multiple types of tissues, such as bone, cartilage, fat, msulce, tendon, etc. It remains a challenge to direct MSCs
to differentiate into a specific type of cells/tissues. Furthermore, it is not well understood how early different lineages diverge
from MSCs. Nonetheless, MSCs represent one of the most promising populations of progenitors for regenerative medicine and tissue
engineering.
Chondrogenesis and cartilage regeneration 309proteins, such as Col10a1.17 Research regarding FGF18 has
yielded conflicting results in the in vitro setting.18,19 How-
ever, FGF18 has been shown to stimulate repair of damaged
cartilage in the setting of osteoarthritis in rats so it is
generally accepted that FGF18 is prochondrogenic.20Transforming growth factor b (TGF-b)/bone
morphogenic protein (BMP) signaling pathway
Members of the transforming growth factor b (TGF-b) su-
perfamily, particularly TGF-bs and BMPs, are essential for
multiple stages of embryonic chondrogenesis.21,22 This
pathway is often utilized to induce chondrocyte differen-
tiation in MSCs and expanded chondrocyte pop-
ulations.21,23e27 TGF-b1 and TGF-b2 have long been known
to serve as major regulators in chondrogenesis and
osteogenesis.28e36 Members of the BMP family are required
for condensation of chondroprogenitor cells and chon-
drocyte differentiation both in vivo and in vitro.37e39 TGF-
b also mediates the end of proliferation and the subsequent
initiation of chondrocyte differentiation.22 This shift fromproliferation to differentiation has been extensively stud-
ied both in vivo during embryonic cartilage development
and in vitro using MSCs.40 Recent investigation in tissue
engineering has focused on developing suitable molecular
scaffolds to deliver TGF-b to damaged articular cartilage
in vivo in order to induce chondrogenic repair of the
damaged cartilage.41 Proper development of join-
tsdanother process involving chondrogenesisdrequires
the activity of several BMPs, including BMP-2, BMP-4, and
growth and differentiation factor-5 (GDF5), another
member of the BMP family.38,42e45 However, exogenous
addition of GDF5 to synovial joints during development
results in fused joints and chondrocyte overgrowth, sug-
gesting that BMP signaling effects are dose-
dependent.38,43,44
TGF-b/BMP signaling primarily activates Smad-
dependent signal transduction pathways in the target
cell.22 There are two types of receptors for TGF-bs, types I
and II; which, upon activation, phosphorylate type-specific
receptor-Smads (R-Smads). Following BMP signaling, acti-
vated Smad1, Smad5, and Smad8 associate with Smad4 and
translocate to the nucleus in order to regulate the
310 J.D. Green et al.expression of genes.37,46,47 In contrast, Smad6 and Smad7
are inhibitory (I-Smads). Smad6 selectively inhibits Smad1/
5/8 signaling, whereas Smad7 inhibits all R-Smad signaling
pathways. Thus, Smad7 can inhibit chondrocyte differen-
tiation at several different stages.22,48 TGF-b can also signal
via the mitogen activated protein kinase (MAPK) proteins
p38, ERK, and JNK in MSCs; which can contribute to the
progression from condensation to differention.49,50,51
Though TGF-b is generally associated with differentia-
tion, BMP signaling appears to play a key role in conden-
sation. The coalescence of small aggregates of
chondroprogenitor cells into a single distinct cluster
in vitro, a prerequisite of differentiation, and the
condensation of limb bud mesenchyme in culture both
require BMP-mediated signaling.37,52,53 Prior to the differ-
entiation of chondroprogenitor cells, TGF-b counteracts
FGF-mediated cell proliferation.22 TGF-b2 and TGF-b3 are
highly expressed in the AER of the developing chick embryo
limb bud, which corresponds to a reduction in cell prolif-
eration.54 Simultaneous downregulation of Gremlin (Grem),
an inhibitor of BMP, was also observed, suggesting that TGF-
b signaling might indirectly inhibit proliferation by inhibit-
ing Grem; thus, the aforementioned downregulation en-
ables BMPs to counteract the proliferative effects of FGF.55
BMP-2 has also been shown to have anti-proliferative ef-
fects in the mouse limb bud AER, opposing the effects of
FGF-4.2,56,57 In addition to inhibiting Grem, TGF-b signaling
has been found to activate the cyclin D kinase (CDK) in-
hibitors p16, p21, and p53, which arrest MSCs in the G1
phase of the cell cycle and induce cellular senescence.22
FGF2 promotes proliferation by inhibiting the expression
of TGF-b2, preventing this senescence.58 TGF-bR1 and
Smad3 expression increased steadily over time in a 3-month
long MSC chondrocyte culture, corresponding directly to an
observed decrease in proliferation and increase in
differentiation.59
In addition to inhibiting proliferation, TGF-b has been
shown to mediate the differentiation of chondroprogenitor
cells into chondrocytes.28,32,60 TGF-b has long been used as
the prototype for growth factor-induced chondrogenesis in
MSCs in vitro.61 TGF-b-mediated Smad2/3 and Smad1/5/8
signaling is essential for the initiation of chondrogenic dif-
ferentiation.22 TGF-b also activates MAPK proteins p38,
ERK, and JNK in MSCs, which lead to downregulation of N-
cadherin expression by blocking Wnt-mediated b-catenin
nuclear translocation.49 Reducing N-cadherin expression is
a necessary step to proceed from condensation to differ-
entiation.62e64 Inhibiting TGF-b signaling during chondro-
genesis by blocking TGF-bR2 expression alters
differentiation and digital joint formation without affecting
prior stages of chondrogenesis.65e67
BMPs also take part in the process of chondrocyte dif-
ferentiation. Simultaneous removal of either BMPR1A and
BMPR1B or SMAD1 and SMAD5 from chondrogenic cells
blocks the formation of the endochondral skeleton in mice,
suggesting that those cells are unable to form carti-
lage.37,39,68 Application of BMP-2, 4, 6, 7, 9, 13, or 15 can
increase in vitro articular chondrocyte synthesis of type II
collagen.22,38,69,70 Although BMPs take part in the seemingly
mutually exclusive condensation and differentiation stages,
it is likely that the effects of BMP signaling are time-
dependent and concentration-dependent.38Axin, a protein best known for its role in the b-catenin
degradation complex, also interacts with the TGF-b
signaling pathways during chondrogenesis.22 During chon-
drocyte differentiation/maturation, Axin acts as an adaptor
between TGF-bR and SMAD3. This adaptor interaction al-
lows for greater phosphorylation and activation of SMAD3
by TGF-bR, which enhances the effect of TGF-b signaling.
Axin further enhances this signal by a similar facilitation of
TGF-bR phosphorylation of the inhibitor SMAD7, resulting in
SMAD7 degradation.71,72 Disrupting Axin2 signaling has also
been shown to accelerate chondrocyte maturation, further
supporting Axin’s role in chondrocyte differentiation.73
Given that Axin also mediates the downregulation of Wnt/
b-catenin signaling, this activity is further suggestive of the
importance of the switch from Wnt-mediated signaling
during condensation to TGF-b signaling during
differentiation.
After chondrocytes have differentiated, continued TGF-
b-mediated SMAD1/5/8 signaling leads to cartilage hyper-
trophy.22,74 This finding is primarily relevant to efforts to
use tissue engineering methods to medically repair
damaged articular cartilage (e.g., in osteoarthritis),
because TGF-b-induced chondrogenesis in MSCs produces
hypertrophic hyaline cartilage.75Wnt/b-catenin signaling pathway
It is well established that Wnt signaling is involved in
chondrogenesis, but the exact nature of its involvement
remains to be fully elucidated. Several studies have
demonstrated that Wnt signaling is capable of both
enhancing and inhibiting chondrogenic differentiation of
adult and embryonic progenitor cells.75e78 These antago-
nistic effects may be the product of a variety of factors
including the phase of differentiation of target cells, level
of Wnt activity, particular type of Wnt signal, and even
crosstalk with other signaling pathways, such as the TGF-b/
BMP signaling pathway.77,79,80 The canonical Wnt/b-catenin
pathway is the most studied with regards to chondrogenesis
and will be focused on herein.
Although Wnt signaling’s role in the early phase of
chondrogenesis has not been well characterized, functional
analysis of a few specific Wnt proteins has revealed Wnt to
be an important player in chondrogenic cell migration and
condensation.81,82 It has been demonstrated, for example,
that Wnt5b plays a regulatory role in chondroprogenitor cell
migration through activation of the planar cell polarity
pathway (to be discussed further), and decreases adhesion
by inhibiting expression of a destabilizing cadherin receptor
as well as exerting regulatory effects on a variety of cad-
herins.94 Wnt5a has also been associated with cellular
migration and focal adhesion dynamics in embryonic fibro-
blasts, but in contrast to Wnt5b, it has been shown to
promote cellular adhesion.81,83,84
Progenitor cell migration and cellecell adhesion regu-
lation are crucial steps in early chondrogenesis and are, in
part, mediated by Wnt signaling.52 During development of
pharyngeal arches, cranial neural crest cells (CNCCs) un-
dergo convergence and extension to form a cartilaginous
framework for future ossification.85e88 Wnt activation of
the non-canonical planar cell polarity pathway is a
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migration and condensation patterns.89e91 It has been well
documented that the absence of Wnt signaling results in
craniofacial deformities in vertebrates, confirming the
importance of Wnt signaling in chondrogenic cell migration
and condensation.92e95 Wnt-mediated CNCC migration and
condensation have been studied in zebrafish, in which it has
been demonstrated that Wnt9a knockout results in severe
craniofacial malformations.96,97 These findings do not pro-
vide extensive insight into the mechanisms of Wnt’s medi-
ating effects on cell migration and condensation, but they
do demonstrate the importance of Wnt signaling in these
processes.
Several Wnt proteins, including Wnt1, Wnt3a, Wnt4,
Wnt5b, and Wnt8 have been shown to signal via the ca-
nonical pathway in vitro.76,77,98e100 However, their effects
on chondrogenesis are inconsistent. Wnt1, Wnt4, and Wnt8
have reportedly been shown to inhibit differentiation of
chondrocytes whereas Wnt3a and Wnt5b stimulate it.
Similarly, Wnt3a and Wnt5b have been shown to inhibit
chondrocyte hypertrophy, an important process in the
latter stages of chondrogenesis, while Wnt4 and Wnt8
stimulate it.89 Other Wnt proteins have similar contradic-
tory effects: Wnt7a inhibits chondrocyte differentiation,
Wnt9a inhibits both chondrocyte differentiation and hy-
pertrophy, Wnt5a stimulates chondrocyte differentiation
but delays hypertrophy, and Wnt11 seems to have no effect
on chondrogenesis.101e103 This complicated network of
seemingly contradicting effects, which can be found in
Table 1, may be the result of Wnt activating two or more of
the aforementioned intracellular cascades with effects that
modulate each other. For example, Wnt5b has been shown
to both stimulate and repress chondrocyte differentiation
via the canonical b-catenin and non-canonical JNK path-
ways, respectively.78,81 Similarly, Yan et al showed that
Wnt3a signals via the canonical signal cascade as well as the
JNK pathway.104 Additionally, as already mentioned,
crosstalk between other signaling pathways such as TGF-b
and BMP may be partially responsible for the opposing ef-
fects of different Wnt proteins.
Furthermore, the expression patterns of Wnt proteins
differ based on the proliferating cell type. Hartmann et al
demonstrated that Wnt4, Wnt5a, Wnt5b, and various
components of the Wnt cascade show remarkably different
expression patterns in perichondrial cells versus chon-
drocytes (Fig. 2). Artificial induction of inappropriate WntTable 1 Effect of Wnt signaling on chondrocyte differ-
entiation and hypertrophy.
Wnt Differentiation Hypertrophy References
Wnt1 Inhibits e 318
Wnt3a Stimulates Inhibits 77,319
Wnt4 Inhibits Stimulates 76,320
Wnt5a Stimulates Inhibits 76,321
Wnt5b Stimulates Inhibit 76,81
Wnt8 Inhibits Stimulates 3,19,322
Wnt7a Inhibits e 77
Wnt9a Inhibits Stimulates 96,97,124
Wnt11 No effect No effect 103signals in either cell type resulted in severe chick wing
malformation.76 Other research has found that Wnt5a and
Wnt11 are expressed preferentially in the perichondrium,
Wnt5b in the prehypertrophic chondrocytes, and Wnt7a and
Wnt8 in the mature chondrocytes.76,98,102,105,106 The highly
localized and sensitive expression pattern of Wnt genes
suggests that Wnt signaling is a tightly regulated and highly
specific process critical for chondrogenesis.
The positive mediating effect of Wnt and Wnt agonists
on chondrogenesis has been observed in pericytes, adult
marrow stromal cells, chondroblast precursors, and other
multipotent mesenchymal cell types.76,77,80 This has been
documented to occur through the canonical pathway
involving downstream stabilization of cytoplasmic b-cat-
enin and resultant lymphoid enhancing factor (LEF)/T-cell
factor (TCF)-induced gene transcription, which, among
other functions, promotes chondrogenesis.107e109
Hedghog signaling pathways
Sonic hedgehog (Shh) signaling
Shh is a morphogenic protein that plays an important role in
the developing limb and midline structures of the brain.110
While it is primarily known for its morphogenic properties in
the developing limb cartilage, Shh remains an important
regulator of chondrogenesis in adults and therefore war-
rants attention regarding its potential therapeutic impact.
Shh signaling, along with the BMP pathway, is critically
important in early chondrogenesis due to its role in deter-
mining cell fate. For example, the relative timing of Shh
and BMP signaling controls whether presomitic mesoderm
will adopt either a chondrogenic or lateral plate mesoderm
fate. Shh, like other hedgehog proteins, signals through
effector molecules known as Gli factors. These Gli factors
can be silenced through a direct interaction with GATA
factors, whose transcription is BMP-dependent.111 The
strict regulation of this feedback loop explains why the
timing of Shh and BMP signaling is crucial during the early
stages of chondrogenesis.
In addition to its role in early chondrogenesis, Shh helps
drive chondrogenesis through robust synergism with other
prochondrogenic factors.112e114 Shh and BMPs work
together to establish a positive regulatory loop with Sox9
and Nkx3.2, a transcription factor that increases Sox9
expression.115e118 Along with establishing this regulatory
loop, transient Shh expression increases target cellular
response to BMP signaling.27,119 In conjunction with Shh’s
synergistic ability, it has been shown to significantly
enhance chondrogenesis in the presence of two members of
the FGF family, FGF2 and FGF8.120,121 Altogether, Shh is an
important prochondrogenic factor that can have a sub-
stantial impact on cartilage tissue engineering because of
its synergistic activity with many other chondrogenesis-
mediating factors.
Indian hedgehog (Ihh) signaling
Ihh, another member of the mammalian hedgehog family of
proteins, is encoded by a mechanosensitive gene and serves
as a regulator for both osteogenesis and chondrogenesis.122
Figure 2 Marker/regulator gene expression in different zones of the growth plate and the perichondrium. The important and
representative marker genes are listed.
312 J.D. Green et al.Ihh is synthesized in prehypertrophic and hypertrophic
chondrocytes and couples chondrogenesis to osteogenesis
through singaling mechanisms involving chondrocytes and
preosteoblasts (Fig. 2).123 Expression of Ihh in prehyper-
trophic and hypertrophic chondrocytes is dependent on
expression of Wnt9a, whose effector b-catenin/Lef1 com-
plex interacts directly with an Ihh promoter.124 Due to its
ability to drive both osteogenesis and chondrogenesis,
precise homeostatic regulation of Ihh expression is crucial
for promoting chondrogenesis over osteogenesis.
Although Ihh is not considered one of the master regu-
lators of chondrogenesis, studies show that in primary MSCs
it is an equally potent inducer of chondrogenesis in com-
parison to TGF-b1 and BMP-2. Solo Ihh expression is suffi-
cient to drive chondrogenesis in an acute injury model, but
its major prochondrogenic effects are carried out through
interactions with other factors.125 For example, endoge-
nously produced Ihh is thought to mediate TGF-b1-induced
chondrogenesis in human bone marrow stromal cells
(hBMSCs).126,127 Similarly, synergistic interactions between
Ihh and other central regulators of chondrogenesis havebeen characterized and include Runx proteins and FGFs.
Runx2 and Runx3 are essential for chondrocyte maturation
and regulation of limb growth, and these effects are carried
out through Runx-induced expression of Ihh.128,129 Simi-
larly, Ihh works in conjunction with FGF8 during digit
primordia elongation. Like its mammalian hedgehog family
member Shh, Ihh promotes chondrocyte differentiation via
expansion of Sox9 expression. Additionally, Ihh is known to
upregulate the expression of FGF8 in MSCs. It is believed
that these effects stem from FGF8-induced upregulation of
Ihh in MSCs, creating a positive feedback loop that is
antagonized by BMP signaling.130,131
Along with interactions with major signaling pathways,
Ihh expression is regulated by a variety of peptides. The
most well-studied peptide interaction is the Ihh/PTHrP
negative feedback loop. In the growth plate, Ihh produced
by the prehypertrophic and hypertrophic chondrocytes in-
creases expression of PTHrP, which antagonizes Ihh-
mediated differentiation via a protein kinase A-mediated
mechanism. This feedback loop helps to coordinate chon-
drocyte proliferation and differentiation, and this system is
Chondrogenesis and cartilage regeneration 313negatively regulated by retinoic acid.132e135 Sirtuins (Sirts),
a class of proteins with deacylase activity, have been found
to enhance Ihh-mediated chondrocyte differentiation. Sirt6
knockdowns reveal markedly decreased expression of Ihh,
and consequently depressed Ihh-mediated chondrocyte
differentiation.136 In contrast, the oncogene delta-EF1
serves as a negative regulator of Ihh expression, implying
that knockdown of delta-EF1 would actually enhance Ihh-
mediated chondrocyte differentiation at the growth
plate.137Notch signaling pathway
The Notch signaling pathway is a cell signaling pathway
involving one of four transmembrane notch receptors:
NOTCH1-4. The Notch signaling pathway is highly conserved
and it is known to play roles in many developmental and
cell type specification processes.138 Previous studies have
demonstrated differential expression of markers for Notch
signaling during cartilage development, underscoring its
importance in chondrogenesis and suggesting a role in
cartilage tissue engineering.139,140
The function of the Notch intracellular domain (NICD) is
central to Notch-mediated regulation of chondrogenesis.
The NICD, one of the end products of the Notch signaling
pathway, translocates into the nucleus where it complexes
with CSL-type DNA binding proteins CBF1(RBP-J), Su(H), and
Lag-1. During this interaction, NICD converts the afore-
mentioned DNA binding proteins from transcriptional re-
pressors to transcriptional activators.141 These
transcriptional activators go on to induce the transcription
of members of the HES gene family. The HES gene family
encodes for basic helix-loop-helix (bHLH) nuclear proteins
that suppress transcription.142 Members of this family, HES-1
and HEY-1 act on the Sox9 binding site in the col2a1 enhancer
and consequently prevent Sox9-mediated transcriptional
activation of col2a1.143,144 Thus, it is clear that Notch
signaling has the ability to inhibit chondrocytic differentia-
tion through the upregulation of HES-1 and HEY-1 activity.
Although a mechanism detailing one way Notch signaling
can regulate chondrogenesis has been elucidated, there are
no data which suggest a mechanism behind the differential
expression of Notch receptors. NOTCH1 is the most well-
studied receptor with regards to chondrogenesis and is
highly expressed in mesenchymal condensations, pre-
hypertrophic and hypertrophic zones in embryos, and the
surface layer of joint cartilage in mice (Fig. 2). Likewise,
NOTCH2, a modulator of NOTCH1 and NOTCH3 activity, is
broadly distributed throughout proliferating, prehyper-
trophic, and hypertrophic chondrocytes in articular carti-
lage and the epiphyseal growth plate.139,140,145,146 As a
result of these findings, it is commonly accepted that Notch
receptors can serve as markers for chondroprogenitor
cells.147 This differential expression suggests a dual role for
Notch signaling during the early and late stages of
chondrogenesis.
Recent findings have determined that the impact of
Notch signaling on chondrogenesis is conditional. This is
evident by the finding that both overexpression of NICD and
loss of NICD activity result in skeletal malformations due to
defective endochondral ossification.148 These resultssuggest that Notch signaling is necessary for chondrogenesis
to occur completely, although overactivity of the pathway
creates inhibitory effects. We have previously discussed
that increased Notch signaling can inhibit Sox9-induced
chondrogenesis, but the fact that Notch receptors are
highly expressed in chondroprogenitor cells implies that
Notch signaling can maintain proliferating chondrocytes in
their progenitor stage. Karlsson et al have confirmed this
hypothesis by showing that there is high expression of HES-5
in undifferentiated chondroyctes and that downregulation
of HES-5 is required for expression of genes with a hyaline
phenotype.149,150 In summary, current research suggests
that transient Notch signaling is required to prime MSCs for
chondrogenesis, but Notch signaling must be switched off
for chondrogenesis to proceed to completion. As a result,
finding ways to regulate Notch signaling activity may prove
to have a significant impact on cartilage tissue engineering.
Hypoxia and angiogenic signaling pathways
Hypoxia signaling
Hypoxia-inducible factors (HIFs) are transcription factors
that respond to decreases in oxygen, or hypoxia, in the
cellular environment. It is well known that cartilage is a
largely avascular tissue, and as a result, chondrocytes
almost always reside in a state of mild hypoxia.151,152 Se-
vere hypoxia (1% O2 saturation) slows cell differentiation,
including chondrogenesis, through decreases in gene
expression secondary to cell damage.153 The link between
mild hypoxia (5% O2 saturation) and the presence of chon-
drocytes is of tremendous importance for cartilage tissue
engineering, and HIFs play a crucial role in establishing this
link. Because chondrocytes primarily reside in a hypoxic
environment, it is conceivable that HIFs are involved
throughout the entirety of chondrogenesis. In early chon-
drogenesis, HIFs help maintain the chondrocyte phenotype
and ensure survival of proliferating chondroprogenitor
cells.154e156 HIFs also enhance chondrocyte secretion of
ECM and alter gene expression in chondroprogenitor cells.
Specifically, HIFs enhance expression of col2a1, Sox9,
aggrecan, CD44, CD105, and PDGF receptor a; while
inhibiting the expression of col1a1, col1a2, and
col3a1.157e162 There are 6 members of the HIF family, but
HIF-1a and HIF-2a are the primary HIFs that have been
shown to promote chondrogenesis.
There is a competing body of evidence regarding HIF-
1a’s role in chondrogenesis, but many researchers have
shown that HIF-1a is critical to the survival of the hypoxic
chondrocyte.163e166 HIF-1a accomplishes this function pri-
marily through two mechanisms, the first of which involves
interaction of HIF-1a with the cAMP response element-
binding protein binding protein/p300. This complex serves
as a coactivator for HIF-1a and enhances the transcription
of HIF-1a’s target genes.167 The second mechanism by
which HIF-1a promotes hypoxic chondrocyte survival is
through upregulating expression of heat shock proteins
Hsp90 and Hsp70. HIF-1a-mediated increases in Hsp90 and
Hsp70 expression is also believed to be the mechanism of
action of protection against chondral inflammation.168,169
These important signaling pathways initiated by HIF-1a
314 J.D. Green et al.are stabilized in vivo by Runx2, which blocks the interaction
between von Hippel-Lindau protein and HIF-1a.170
While it has been established that HIF-1a serves as the
primary HIF expressed to maintain the chondrocyte
phenotype, HIF-2a has emerged as the primary HIF involved
in chondrocyte differentiation. HIF-2a induces chondrocyte
differentiation by enhancing the transcription of many
prochondrogenic genes, including the Sox trio, aggrecan,
versican, Col2a1, Col9a1, Col10a1, and Col11a1.171 HIF-2a-
mediated chondrogenesis is reinforced via increased ac-
tivity of the PI3K-Akt signaling pathway.172
Vascular endothelial growth factor (VEGF) sigaling
pathway
VEGF, which is secreted by hypertrophic chondrocytes, is a
signaling protein that stimulates vasculogenesis and angio-
genesis, thus making a proosteogenic factor.173,174 As pre-
viously stated, angiogenesis reduces the severity of hypoxic
states, which is needed to maintain the chondrocyte
phenotype. Vascularization of cartilage tissue results in loss
of phenotype, and subsequently, differentiation of chon-
drocytes to bone. Therefore, regulation of VEGF expression
is important in maintenance of cartilage tissue.
Much of the research regarding VEGF’s impact on chon-
drogenesis comes in the form of knockout studies. Here, we
have attempted to summarize the most pertinent results.
Antibodies against VEGF inhibit migration of chon-
droprogenitor cells in vitro. These results are also seen
when chondroprogenitor cells are introduced to media
containing antibodies against VEGF receptor 2, and are
consistent with the findings that VEGF plays a key role in
chondrocyte metabolism and accelerates the proliferation
of chondroprogenitor cells in vitro.175e178 In contrast, Flt-1,
a soluble VEGF antagonist, has been shown to improve BMP-
4- and TGF-b3-induced chondrogenesis.178,179 Similar re-
sults were seen with administration of sFlk-1 or
Bevacizumab.180
In addition to helping determine cell fate by disrupting
hypoxia, VEGF is involved in different phases of cartilage
tissue development. VEGF is important for the formation of
blood vessels needed for limb development. In this capac-
ity, VEGF serves as the effector molecule of Sphingosine-1-
Phosphate receptor, a G-protein coupled receptor central
to endothelial cell morphogenesis and vascular matura-
tion.181 Exogenous administration of VEGF to the devel-
oping limb markedly increases blood vessel number and
density, but it inhibits digit development due to repression
of Sox9 expression.182 Alternatively, complete inactivation
of VEGF-A in areas of col2a1 expression results in embryonic
lethality.183 These results imply that a closely regulated
level of VEGF expression is necessary for proper limb
development, a process that includes extensive
chondrogenesis.
Transcriptional regulation of chondrogenesis
SRY-box 9 (Sox9)
Sox9 is a prochondrogenic transcription factor that is
arguably the single most important regulator ofchondrogenesis because high levels of Sox9 are required
for full expression of the chondrocyte phenotype.184 Sox9
expression is induced by compressive force: a variety of
prochondrogenic factors, including RelA, Pref-1, Arib5b;
and two other Sox transcription factors, Sox5 and
Sox6.185e190 As a transcription factor, Sox9’s mechanism of
action is directly related to the genes that it regulates.
Akiyama et al have elucidated that Sox9 interacts with two
binding sites for HMG-domain proteins and activates ele-
ments in the promoters of col2a1, col9a1, col11a2, Bbf2h7-
sec23a, and aggrecan.191e193 Furthermore, Sox9 induces
its own transcription in addition to the transcription of
Sox5 and Sox6, forming the Sox Trio. The individual com-
ponents of the Sox Trio act cooperatively to increase the
expression of the previously discussed gene targets of
Sox9.191,194e196
Sox9 primarily regulates chondrocyte proliferation and
differentiation through direct control of the expression of
many chondrocyte-specific genes. In addition to this
observation, many studies have elucidated Sox9’s role in
earlier phases of chondrogenesis, such as condensation.
Numerous studies show that Sox9 expression levels are
markedly elevated in condensing mesenchymal progenitors,
both in vitro and in vivo, while Sox9 knockout mice are
unable to condensate mesenchymal cells.197e199 As previ-
ously stated, FGF2 induces chondrocyte proliferation by
upregulating basal expression levels of Sox9.200,201 Sox9
then potentiates BMP2’s prochondrogenic properties and
inhibits BMP2-induced osteogenic differentiation and
endochondral ossification.202 While this relationship has
been well studied, it is only one of many Sox9 interactions
that help regulate chondrogenesis.
Sox9’s ability to promote chondrocyte differentiation
and maturation is dependent upon the expression of coac-
tivators of Sox9-mediated transcription and the silencing of
factors that stimulate osteogenesis. Many coactivators of
Sox9 expression have been identified in MSCs, including
Paraspeckle regulatory protein 54-kDa nuclear RNA-binding
protein (p54nrb), Smad proteins 2 and 3, peroxisome
proliferator-activated receptor g co-activator 1a (PGC-1a),
Tip60, Lc-Maf, CypA, Scleraxis/E47, and p300.203e209 Having
so many coactivators most likely plays a role in fine-tuning
local expression levels of Sox9, which may prove advanta-
geous within the field of cartilage tissue engineering. Sox9’s
major antagonist is Runx2, the master regulator of osteo-
genesis. Expression of Sox9 inhibits early and late osteo-
genic differentiation by depressing the expression of
Runx2, as well as osterix, a transcription factor for osteo-
genic differentiation, col1a1, and col10a1.197,202,210 In
addition to regulating the expression of proosteogenic
transcription factors and genes, Sox9 also targets Wnt/b-
catenin promoters for degradation by the ubiquitination/
proteasome system.198,211 Finally, Sox9 activity can be
blunted by its two primary negative regulators, Runx2 and
RhoA protein.211,212Runt-related transcription factors (Runx)
Runx proteins, including Runx1, Runx2, and Runx3, are a
family of transcription factors that play significant roles in
organogenesis and embryonic patterning. While all 3
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chondrogenesis, Runx1 is believed to have a minimal effect
on chondrogenesis and will not be discussed in this
review.213
Runx2 and Runx3 are essential for chondrocyte matura-
tion, but Runx2 serves a secondary role as a potent inducer
of osteogenesis. The regulation of osteogenesis and chon-
drocyte proliferation by Runx2 is accomplished through an
interaction with PI3K-Akt signaling.214 Regulatory control of
Runx2 is handled primarily by Sox9, as stated previously,
helping to explain Sox9’s apparent dominance over Runx2 in
MSCs destined for a chondrogenic lineage.215 This interac-
tion is further complicated by interactions with CypA, a
positive regulator of both Runx2 and Sox9 expression in
chondroprogenitor cells. Predictably, CypA knockdowns
have depressed chondrogenesis and endochondral ossifica-
tion.208 Nkx3.2 serves as another method for regulatory
control of Runx2. Nkx3.2 represses Runx2 activity through
direct interaction with the Runx2 promoter, and this
repression is required for the progression of BMP-induced
chondrogenesis.216,217
The regulation of Runx2 expression is of extreme
importance with regards to chondrogenesis, given the va-
riety of effects Runx2 expression can have on MSCs.
Col10a1, a type of collagen expressed in hypertrophic
chondrocytes destined for endochondral ossification, is a
direct transcriptional target of Runx2.218 Runx2’s ability to
drive osteogenesis is most likely related to its ability to
cooperate with HIFs to stimulate angiogenesis. As already
discussed, angiogenesis decreases the severity of local
hypoxia which inhibits chondrogenesis while promoting
osteogenesis.219 In addition to driving osteogenesis, Runx2
has also been shown to induce adipogenic differentiation
in vitro.220 Finally, Hinoi et al have shown that Runx2 en-
hances expression of FGF18, a negative regulator of chon-
drocyte maturation, in the perichondrium.221Trico-rhino phalangeal syndrome type 1(Trps1)
Trps1 is a GATA-like transcription factor that serves as a
novel regulator of chondrocyte differentiation and prolif-
eration through regulation of a variety of genes. As a GATA-
like transcription factor, Trps1 acts as a downstream
effector of the Gdf5 signaling pathway to promote both
differentiation and apoptosis.222 Trps1’s versatility as a
transcription factor is linked to its ability to effect
expression levels of key regulators, like Sox9, as well as less
researched gene targets, such as Stat3.223,224 In addition to
its function as a transcription factor, Trsp1 also interacts
with many microRNAs (miRs) and other signaling pathways.
Specifically, Trps1 is responsible for maintaining low levels
of miR-221, which allows MSCs to commit toward the
chondrocyte lineage.225 The interaction between Trps1 and
miR-221 may be a part of a feedback loop, as it has been
shown that Trps1 expression is regulated by seven Runx2-
targeting miRs (miRs-23a, -30c, -34c, -133a, -135a, -205,
and -217).226 Furthermore, Trps1 interacts with Ihh/Gli3
signaling, as evidenced by studies in which Trps1 knockout
mice overexpress PTHrP and inhibit Ihh-mediated chon-
drogenesis via the Ihh/PTHrP negative feedback
loop.227,228MIA/CD-RAP in chondrogenic differentiation
The MIA/CD-RAP gene is a gene locus that encodes for the
melanoma inhibitory activity protein (MIA) and the
cartilage-derived retinoic acid-sensitive protein (CD-RAP).
Normal expression of this gene locus is limited to cartilage,
but pathological expression does occur in melanoma and
chondrosarcoma.229 Given the cartilage-selective expres-
sion of the MIA/CD-RAP gene, it makes sense that these
proteins are noteworthy regulators of chondrogenesis.
Regulation of chondrogenesis by MIA/CD-RAP occurs
through two primary mechanisms. First, transcription fac-
tor YBX1 has been shown to mediate MIA/CD-RAP-
dependent activation of p54nrb transcription.230 Second,
consistent data support the concept of MIA/CD-RAP-
mediated inhibition of ERK signaling. ERK is known to
block chondrogenic differentiation, and its inhibition helps
drive chondrogenesis.231 Through these two mechanisms, it
has become clear that MIA/CD-RAP proteins are required
for chondrocyte differentiation. This is confirmed by the
finding that MIA knockout mice show enhanced chondrocyte
proliferation but delayed and defective differentiation,
which can be rescued by decreasing AP1 and CRE activ-
ity.230,232 Given the close proximity of the MIA and CD-RAP
genes, alterations in transcription often change the
expression of both proteins. Therefore, interactions
involving the promoter region of MIA/CD-RAP have a sig-
nificant impact on the regulation of chondrogenesis. Known
regulators of MIA/CD-RAP expression include delta-EF1,
USF1/USF2, Sox9, retinoic acid, AP-2, and HMGA. Sox9
serves as a positive regulator, while the others serve as
negative regulators.233e236Epigenetic regulations of chrondrogenesis
Histone deacetylase superfamily
Histone deacetylases (HDACs) are a class of enzymes that
remove acetyl groups from histone proteins, allowing
higher affinity DNA binding and consequent inhibition of
transcription. Therefore, it is no surprise that HDACs pri-
marily function as repressors of the transcription of pro-
chondrogenic genes. For example, HDAC1 and HDAC2
repress the expression of cartilage-specific genes in human
chondrocytes.237 Furthermore, LRF-mediated repression of
COMP gene expression and chondrocyte differentiation re-
quires HDAC1 activity.238 HDACs are also known negative
regulators of osteogenesis. Specifically, inhibition of HDAC
activity potentiates BMP9-induced osteogenic signaling in
mouse MSCs and attenuates chondrocyte proliferation and
differentiation.239e242 Similarly, HDAC4 overexpression
promotes chondrogenesis while inhibiting chondrocyte hy-
pertrophy via modulating TGF-b1 activity.243 Negative
regulation of osteogenesis by HDACs may help explain these
findings.
microRNAs (miRs)
MicroRNAs are small, non-coding RNA fragments whose
function involves mRNA silencing and post-transcriptional
Table 2 List of known microRNA expression in human and
mouse MSCs undergoing chondrogenesis.
microRNA Expression References
miR-26b Upregulated 323
miR-28 Upregulated 323
miR-130b Upregulated 323
miR-152 Upregulated 323
miR-193b Upregulated 323
miR-15b Upregulated 324
miR-16 Upregulated 324
miR-23b Upregulated 3,25,325
miR-27b Upregulated 324
miR-140 Upregulated 324
miR-148 Upregulated 324
miR-197 Upregulated 324
miR-222 Upregulated 324
miR-328 Upregulated 324
miR-505 Upregulated 324
miR-127 Upregulated 326
miR-140 Upregulated 326
miR-125b* Upregulated 326
miR-99a Upregulated 326
miR-140* Upregulated 326
miR-181a-1 Upregulated 326
let-7f Upregulated 326
miR-30a Upregulated 326
miR-24 Upregulated 327
miR-101 Upregulated 327
miR-124a Upregulated 327
miR-199a Upregulated 3,28,328
miR-199b Upregulated 327
miR-130b Upregulated 323
miR-193b Upregulated 323
miR-455 Upregulated 329
miR-337 Upregulated 330
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has been well known that microRNAs are important for
developmental timing in both vertebrates and inverta-
brates.244,245 More recent findings have confirmed this
notion, showing that universal disruption of Dicer, a RNA
endonuclease required for microRNA production, results in
embryonic lethality and depletion of pluripotent stem
cells.246,247 These findings, among others, have sparked
significant research interest in the role of microRNAs in
chondrogenesis and their potential therapeutic effects.
MicroRNAs have well characterized effects on both pre-
and post-natal chondrogenesis. Pre-natally, microRNA
expression profiles are extremely important for the devel-
opment of cartilaginous tissues, such as the pharyngeal
arches. For example, Weinholds et al have shown that 10
microRNAs (miRs-23a, -27a, -27b, -140, -140*, -145, -146,
-199a, -199a*, and -214) were specifically expressed in the
developing pharyngeal arches of zebrafish embryos.248 In
addition, post-natal expression profiles of microRNAs and
their effects on chondrogenesis are currently large areas of
research. Studies of many cell types have been conducted,
and the results are much too expansive to be detailed in
this review. With this in mind, we have organized what we
believe to be the most compelling results into Table 2.
A large number of microRNAs have been implicated in
regulating chondrogenesis, but three major target genes
have been implicated in mediating their effects: C/EBPb,
master regulator Sox9, and Adam9. C/EBPb is believed to
protect articular cartilage from degenerative diseases such
as osteoarthritis, and it has been shown to be negatively
regulated by several miRNAs during chondrogenic differ-
entiation of hADSCs.249 Sox9 and Adam9 expressivity are
similarly regulated by a variety of microRNAs. Adam9 is a
negative regulator of chondrogenesis, and its upregulation
could lead to apoptosis of chondrogenic progenitors and
inhibition of MSC migration.250miR-574-3p Upregulated 331
miR-212 Downregulated 326
miR-132 Downregulated 326
miR-143 Downregulated 326
miR-125b-3p Downregulated 326
miR-18 Downregulated 326
miR-96 Downregulated 326
miR-145 Downregulated 332
miR-490-5p Downregulated 333
miR-124 Downregulated 328
miR-199* Downregulated 334,335Implications in cartilage regeneration and
tissue engineering
Cartilage tissue engineering is an area of significant
research amongst engineers and physicians. This research is
of significant therapeutic importances given the high
prevalence of osteochondrodysplasias, including but not
limited to achondroplasia, cleidocranial dysostosis, and
ovine chondrodysplasia. Over the past decade, cartilage
tissue engineering has become dependent upon the selec-
tion of an appropriate cell line, subsequent chondrogenic
differentiation of the selected cell line, and the fabrication
of a biocompatible and mechanically suitable scaffold.251
Given these challenges, current progress has been unable
to show significant improvement in tissue restoration over
proven surgical techniques. Here, we review the most
recent advances in cartilage tissue engineering regarding
overcoming these challenges.
An appropriate cell line for cartilage tissue engineering
must have the ability to differentiate into mature, fully
functional cartilage and maintain a chondrocyte phenotype
long-term. A clear starting point was chondrocytes extrac-
ted from the patient, which have the ability to maintain a
chondrocyte phenotype and remodel. Unfortunately, thesecells are limited in number, and their expansion leads to
dedifferentiation with resultant phenotypic loss.251 Other
cell types explored as candidates for cartilage tissue engi-
neering include human MSCs (hMSCs), adipose-derived stem
cells, and embryonic stem cells. Adipose-derived stem cells
and embryonic stem cells have the ability to undergo
chondrogenic differentiation in response to certain signals,
but they are limited by specific growth requirements and
ethical controversy, respectively.252,253 hMSCs are the most
promising candidate, and use of combinations of growth
factors in hMSCs is the current gold standard for scaffold-
based cartilage tissue engineering.251,254,255
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of which are detailed in this review, provide various ways to
induce chondrogenic differentiation in progenitor cells
(Fig. 3). Current research suggests that among the many
growth factors implicated to have a regulatory effect on
chondrogenesis, TGF-b proteins are the most potent in-
ducers of chondrogenesis in hMSCs. In contrast, other
growth factors, including insulin-like growth factors (IGFs),
FGFs, and PDGFs, appear to mediate chondrocytic physi-
ology to a greater degree than they promote chondro-
genesis in hMSCs.19,61,254e271 In addition to members of the
TGF-b family of proteins, VEGF, hypoxia, and Sox9 have
been shown to induce chondrocytic differentiation in a
variety of 3D scaffolds.272e276 The challenge in using
signaling molecules to optimize cartilage regeneration is
that their regulatory effects depend on a large number of
factors that must be tightly controlled: the dosing and
timing of administration, the cell type, and the medium in
which they act. This phenomenon could help explain the
variability in the results regarding the effects of different
growth factors in cartilage regeneration. Researchers
circumvent this inconsistency by infecting target cells with
adenoviruses expressing a gene of interest and through the
use of gene therapy.277e281
While current research suggests that administration of
biologic agents can delay progression of articular cartilage
degeneration in an experimental setting, few are available
clinically, necessitating consideration for surgical treat-
ment. Although total joint arthroplasty may be the ultimate
end point in many cases, early surgical treatment options
include microfracture, osteochondral auto- or allograft
transfer, and autologous chondrocyte implantation (ACI).
The determination of which method provides the ideal so-
lution depends on the size and location of the lesion, pa-
tient age and activity level, and concomitant pathology. In
ACI, a full-thickness sample from a low-weight-bearing re-
gion of the joint is collected by punch biopsy and then
implanted into the debrided cartilage defect and covered
by a membrane. When successful, this technique canFigure 3 Currently identified regulators of chondrogenic diffe
transcription factors, microRNAs and other regulators are listed. Po
inhibitory regulators are shown in red at the bottom panel.produce a greater amount of hyaline-like cartilage at the
repair site. Limitations of the technique include the need
for two separate surgical procedures, a prolonged recovery
time, and increased procedural complexity.282 In addition,
the procedure has a comparatively high reoperation rate
and cost is prohibitive for many patients. Other early sur-
gical interventions, including matrix-induced autologous
chondrocyte implantation (MACI), have had promising
histological results, but superiority over ACI remains
unproven.283,284
The function of a tissue engineering scaffold is to pro-
vide a temporary structure on which cells seeded within the
biodegradable matrix synthesize new, natural tissue.
Scaffold-based techniques are preferred over scaffold-free
approaches because they increase control over filling de-
fects, eliminate the complications associated with a surgi-
cal donor site, shorten recovery time, and are associated
with a reduced risk of dedifferentiation.285 Ex vivo studies
have shown that successful cartilage regeneration is
dependent on both the chondrocyte proliferation rate and
on the differentiation capacity of stem cells within a 3D
scaffold. Taken together with evidence that cartilage pro-
duction varies with scaffold architecture, the importance
of choosing the appropriate scaffold for cartilage tissue
engineering is clear.286e288 The two most well-studied types
of scaffolds with regards to cartilage tissue engineering are
poly(a-hydroxy esters) and hydrogels. Poly(a-hydroxy es-
ters) are the most commonly used synthetic polymers for
cartilage tissue engineering, while poly(lactic acid) (PLA)
and poly(lactic-co-glycolic acid) (PLGA) are the most
investigated. Both in vitro and in vivo studies have
demonstrated that progenitor cells cultured on PLA or PLGA
scaffolds retain chondrocyte phenotype and produce
cartilage-specific ECM.289e297 In contrast, hydrogels are
cross-linked polymer networks that have the ability to
absorb large amounts of water, making them attractive
scaffolds for engineering tissues with high water content,
such as cartilage.251 Despite theoretical strengths in the
design, use of hydrogel scaffolds has failed to improverentiation from MSCs. Currently reported signaling molecules,
sitive regulators are shown on the top panel in green, while the
318 J.D. Green et al.clinical outcomes when compared to the less expensive
poly(a-hydroxy esters).
Recently, there has been a growing interest in the un-
derstanding of the mechanobiology of MSCs, given that
mechanical factors are known to influence the structure
and function of musculoskeletal tissues at all stages of
life.298,299 A significant proportion of the current research
in cartilage tissue engineering is directed at discerning how
mechanical stimulation induces chondrogenesis in chon-
droprogenitor cells, and how scientists can use these signals
to drive cartilage tissue production. However, the molec-
ular mechanisms of mechanical signal transduction in
chondrocytes and chondroprogenitor cells are still unclear.
Current theories implicate ion channels, primary cilia, the
nucleus, and the cytoskeleton as potential transducers of
mechanical signals in these cells.300e303 Regardless of the
molecular mechanism, it has been well established that a
variety of forms of mechanical stimulation in MSCs can
produce a prochondrogenic state that is favorable for
cartilage regeneration and repair. For example, Choi et al
showed that low-intensity ultrasound enhanced chondro-
genesis in MSCs cultured in fibrin-hyaluronic acid.304 Like-
wise, Kupcsik et al showed that mechanical stimulation of
multipotent stem cells enhanced collagen type X and
lubricin expression.305
Another method employed by researchers to overcome
the previously described challenges of cartilage tissue en-
gineering is the use of bioreactor systems to enhance the
growth of cartilaginous constructs. Bioreactor systems have
emerged as valuable enhancers of cartilage tissue engi-
neering because they accelerate chondrocyte growth by
supplying nutrients or mechanical stimulation.251 Biore-
actor systems come in two forms: loading reactors and
hydrodynamic reactors. Loading reactors, hydrodynamic
reactors, and combinations of the two have all been shown
to expedite the rate and quality of cartilaginous tissue
growth.263,297,306e312 Promising results in cartilage tissue
engineering have been achieved through the utilization of
self-assembling MSCs in a bioreactor model. Self-assembling
MSCs were directed to form condensed mesenchymal
bodies (CMBs) and were fused together with the aid of press
molding.313e317 This novel approach has enabled a break-
through in the ability to engineer human cartilage from
MSCs with the same physiological Young modulus and fric-
tion coefficient.313Concluding remarks and future directions
Regulation of chondrogenesis and cartilage tissue engi-
neering remain areas of significant research given the
increasing prevalence of osteodegenerative disease and
orthopedic trauma. Cartilage tissue engineering has been
complicated by three main challenges: production of a
chondrogenic progenitor cell line that can proliferate and
differentiate into mature chondrocytes, finding biological
factors that can facilitate the proliferation and differenti-
ation of chondrogenic seed cells, and finding biomaterial
scaffolds that provide a 3D architecture resembling the
cartilaginous matrix. While many biological regulators have
been identified, implantation of chondrocytes grown
in vitro has failed to yield significant clinical results. Theapplication of bioreactor systems, which allows scientists
and physicians to deliver nutrients to a largely avascular
tissue, has yielded the most promising results and appears
to be the future of cartilage tissue engineering.Conflict of interest
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